A director at MongoDB Inc sold 31,000 shares at 320.277USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Voyage AI Still in the Early Innings of Integration; Embedding Models Still in Early Innings. The company’s recent acquisition of Voyage AI remains a critical part of MDB’s AI strategy for building reliable AI apps and reliable models by connecting private and proprietary customer data directly to
A Closer Look at FY2Q26 (July) ResultsRevenueTotal revenue of $591.4 million (up 24% y/y) came in well above both the Street’s $553.9 million estimate and the company’s guidance range of $548.0 million to $553.0 million reflecting the strength of its platform approach.Subscription revenue came in a
TELA Bio Reports Second Quarter 2025 Financial Results MALVERN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the second quarter ended June 30, 2025. Recent Highlights Delivered revenue of $20.2 million in the second quarter 2025, representing growth of 26% over the prior year period and sequential growth of 9% over the first quarter of 2025;Increased demand for OviTex® and OviTex PRS Reinforced Tissue Matrix produ...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted ...
The Tile Shop Reports Second Quarter 2025 Results MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, today announced results for its second quarter ended June 30, 2025. Second Quarter 2025 Summary Net Sales Decreased 3.4%Comparable Store Sales Decreased 3.5% Gross Margin of 64.4%Net Income of $0.4 Million and Adjusted EBITDA of $4.9 MillionNo Debt Outstanding and $27.8 million of Cash at Quarter-End Management Commentary – Cabell Lolmaugh, CEO “We bel...
The Tile Shop to Host Second Quarter 2025 Earnings Conference Call MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone tiles, man-made and luxury vinyl tiles, setting and maintenance materials, and related accessories, today announced that the Company will release financial results for the second quarter ended June 30, 2025, at 7:00 a.m. Eastern Time on Thursday, August 7, 2025. The Company will host a conference call via webcast for investors and other interested parties beginning at 9:00 a.m. East...
The Tile Shop Debuts Exclusive Designer Tile Collection With Artist Laura Park The new collaboration brings Park’s vibrant, painterly aesthetic to tile for the first time MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- The Tile Shop (), a specialty retailer of natural stone and man-made tiles, is proud to announce the launch of an exclusive new collaboration with acclaimed artist and designer Laura Park. , available now, showcases Park’s signature bold brushwork, joyful color palettes, and modern abstract style across a fresh, artistic range of tiles crafted to bring warmth and creativi...
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45th Annual Growth Conference. TELA’s management is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference at 10:00 am ET on August 13th, 2025. Interested parties can access the live and archived webcast at . About TELA Bio...
TELA Bio to Announce Second Quarter 2025 Financial Results MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2025 financial results on Monday, August 11, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Second Quarter Earnings Conference Call and Webcast DetailsInves...
AI Revolution All Starts With the Godfather of AI Jensen and NvidiaMajor conglomerates across the US and China are looking to become the first major player to control the next big chip in this tech ecosystem, but this battle is now all in the hands of Nvidia and Jensen with NVDA’s chips becoming th
The Tile Shop Expands Exclusive Collaboration With Jeffrey Alan Marks, Launching Two New Coastal-Inspired Designs MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- The Tile Shop, a leading specialty retailer of natural stone and specialty tiles, is proud to announce the expansion of its exclusive Jeffrey Alan Marks Collection with the debut of two new tile designs: Natural Zen Birchwood and Sand Dollar. These new designs reflect Marks’ signature California-casual aesthetic and offer customers elevated options for creating timeless, relaxed spaces with natural texture and coastal-i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.